These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28083070)

  • 1. Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations.
    Rider P; Carmi Y; Cohen I
    Int J Cell Biol; 2016; 2016():9259646. PubMed ID: 28083070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologics for targeting inflammatory cytokines and their clinical application].
    Chen J; Xie M; Li L; Liu D; Liu M
    Sheng Wu Gong Cheng Xue Bao; 2019 Jun; 35(6):1009-1020. PubMed ID: 31231997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
    Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation.
    Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH
    Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.
    Balato A; Scala E; Balato N; Caiazzo G; Di Caprio R; Monfrecola G; Raimondo A; Lembo S; Ayala F
    Expert Opin Biol Ther; 2017 Nov; 17(11):1363-1374. PubMed ID: 28791896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
    Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytokines in rheumatoid arthritis: inhibition of cytokines in therapeutic trials.
    Moreland LW
    Drugs Today (Barc); 1999; 35(4-5):309-19. PubMed ID: 12973435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
    Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cytokine therapeutics and infections.
    Dinarello CA
    Vaccine; 2003 Jun; 21 Suppl 2():S24-34. PubMed ID: 12763679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine blockade in inflammatory bowel diseases.
    Perrier C; Rutgeerts P
    Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines of the IL-1 family: recognized targets in chronic inflammation underrated in organ transplantations.
    Striz I
    Clin Sci (Lond); 2017 Sep; 131(17):2241-2256. PubMed ID: 28798075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
    Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K
    BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.
    Dinarello CA
    J Infect Dis; 1991 Jun; 163(6):1177-84. PubMed ID: 2037782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of periodontitis: role of cytokines in host response.
    Deo V; Bhongade ML
    Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases.
    Le Goff B; Bouvard B; Lequerre T; Lespessailles E; Marotte H; Pers YM; Cortet B
    Mediators Inflamm; 2019; 2019():8659302. PubMed ID: 31485194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-cytokine therapy in systemic lupus erythematosus.
    Smolen JS; Steiner G; Aringer M
    Lupus; 2005; 14(3):189-91. PubMed ID: 15807194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.